Adipocytokines, inflammatory, epigenetic instability & angiogenesis biomarkers in type 2 diabetic Egyptian women with breast cancer

Diabetes Metab Syndr. 2019 Jan-Feb;13(1):24-29. doi: 10.1016/j.dsx.2018.08.005. Epub 2018 Aug 11.

Abstract

Obesity is the main determinant of type 2 diabetes. Some adipocytokines play important roles in diabetic complications. Lipid transport is an important aspect of lipid metabolism in cancer. Present study aimed to evaluate the effect of some adipocytokines, inflammatory, epigenetic instability & angiogenesis biomarkers in type 2 diabetic Egyptian women with breast cancer. Study Design was performed on eighty females divided into 20 healthy subjects (Group I), 20 patients with type 2 diabetes (Group II), 20 patients with breast cancer (Group III) & 20 patients with diabetes and breast cancer (Group IV). Demographic data & body mass index have been collected. Biochemical analysis included fasting & postprandial blood glucose, lipid profile, fatty acid-binding proteins-4 (FABP-4), tumor necrosis factor-α (TNF-α), vascular endothelial growth factor (VEGF), 8-hydroxy-2'-deoxyguanosine (8-OHdG) & thioredoxin reductase (TrxR) activity. Results revealed significant increase in FABP-4, TNF-α, VEGF, 8-OHdG and significant decreased TrxR activity in diabetic patients with breast cancer in comparison with other groups. These changes were evident in breast cancer subjects than diabetic and healthy cases and in diabetic than healthy cases. Conclusion: This study confirmed the role of FABP-4 in pathogenesis of type 2 diabetes & breast cancer via enhancing angiogenesis, inflammatory and epigenetic instability biomarkers.

Keywords: 8-Hydroxy- 2′-deoxyguanosine; Fatty acid-binding proteins-4; Thioredoxin reductase; Tumor necrosis factor-α; Vascular endothelial growth factor.

MeSH terms

  • Adipokines / blood*
  • Angiogenesis Modulating Agents / metabolism*
  • Biomarkers / analysis*
  • Breast Neoplasms / blood
  • Breast Neoplasms / etiology*
  • Breast Neoplasms / pathology
  • Case-Control Studies
  • Diabetes Mellitus, Type 2 / complications*
  • Diabetes Mellitus, Type 2 / genetics
  • Egypt
  • Epigenesis, Genetic*
  • Fatty Acid-Binding Proteins / blood
  • Female
  • Follow-Up Studies
  • Genomic Instability
  • Humans
  • Inflammation Mediators / blood*
  • Middle Aged
  • Obesity / blood
  • Obesity / complications
  • Obesity / pathology
  • Prognosis
  • Vascular Endothelial Growth Factor A / blood

Substances

  • Adipokines
  • Angiogenesis Modulating Agents
  • Biomarkers
  • FABP4 protein, human
  • Fatty Acid-Binding Proteins
  • Inflammation Mediators
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A